Lipella pharmaceuticals to present at propthink digital investor conference

Pittsburgh, feb. 20, 2024 (globe newswire) -- lipella pharmaceuticals inc., (nasdaq: lipo) ("lipella," "our," "us" or the "company"), a pioneering, clinical-stage pharmaceutical company, announced today that chief medical officer dr. michael chancellor will present at the propthink digital investor conference's key opinion leader (kol) discussion on friday, february 23, 2024, at 2 pm et. dr. chancellor's presentation will be titled: “urologist talks bladder cancer and lasting side effects”.
LIPO Ratings Summary
LIPO Quant Ranking